Abstract
This illustrated review focuses on the development of inhibitors in patients with congenital hemophilia, which is the most serious treatment-related complication in these patients. Hemophilia A (HA) is an inherited X-linked bleeding disorder affecting 1:5000-10 000 newborn males worldwide. It results from the deficiency of coagulation factor VIII (FVIII), due to mutation(s) in its coding gene (F8). Treatment requires administration of FVIII-containing products either on demand or as prophylaxis, which can induce inhibitor development in 20%-35% of patients. Inhibitors are alloantibodies that neutralize the procoagulant activity of exogenous FVIII. During the initial administration of FVIII-containing products, patients with HA can develop a proinflammatory immune response with synthesis of anti-FVIII IgG1, which has no FVIII inhibitory activity. However, in patients with inhibitors, immune response shifts toward an anti-inflammatory/regulatory pattern favoring the synthesis of anti- FVIII IgG4 antibodies. Patients with inhibitors present with bleeding episodes that are difficult to control, and they have reduced response to FVIII replacement. Currently, immune tolerance induction is the available treatment for eradication of pe...Continue Reading
References
Nov 22, 1984·Nature·J GitschierR M Lawn
Feb 21, 2006·Thrombosis Research·Hong FangHongbao Wang
Feb 10, 2007·Blood·Samantha C GouwH Marijke van den Berg
Apr 26, 2007·Journal of Thrombosis and Haemostasis : JTH·S C GouwJ G van der Bom
Nov 6, 2008·Journal of Thrombosis and Haemostasis : JTH·P C ter AvestUNKNOWN CANAL Study Group
May 26, 2009·Experimental Hematology·Margaret V RagniLina Lu
Sep 18, 2010·Clinical and Experimental Immunology·D G ChavesO A Martins-Filho
Sep 29, 2011·Journal of Pharmaceutical Sciences·Puneet GaitondeSathy V Balu-Iyer
Dec 18, 2012·Blood·Shawn F J WhelanBirgit M Reipert
Dec 18, 2014·Blood·Christoph J HofbauerBirgit M Reipert
Feb 25, 2015·Haemophilia : the Official Journal of the World Federation of Hemophilia·S A L MontalvãoM C Ozelo
Dec 5, 2015·Haematologica·Nicoletta SorvilloJan Voorberg
May 26, 2016·The New England Journal of Medicine·Flora PeyvandiFrits R Rosendaal
Sep 20, 2017·Human Gene Therapy·Junjiang SunChengwen Li
Dec 13, 2017·Seminars in Thrombosis and Hemostasis·Assaf Arie BargGili Kenet
Jun 5, 2018·Seminars in Thrombosis and Hemostasis·Sandrine DelignatUNKNOWN ABIRISK consortium
Jun 13, 2019·Blood·H Marijke van den BergUNKNOWN PedNet Study Group
Citations
Feb 3, 2021·Blood·Joseph S GishP Clint Spiegel
Jun 16, 2021·Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis·Letícia L JardimSuely M Rezende
Nov 17, 2021·Expert Opinion on Biological Therapy·Steven W PipeOscar G Segurado